Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The COVID-19 virus has been named “SARS-CoV-2” (severe acute respiratory syndrome coronavirus 2) and the disease it causes has been named “Coronavirus Disease 2019” (COVID-19). The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019. Life sciences companies are putting all of their efforts into finding a treatment or developing a vaccine for this disease. PharmaShots is keeping a track of all of the important updates in the Life-sciences sector, where we have covered news updates regarding collaborations, clinical trials, funding, and regulatory guidelines related to the COVID-19 from Jan to date.
1. Kantaro Receives FDA Emergency Use Authorization for Semi-Quantitative COVID-19 Antibody Test Kit that Detects the Presence and Level of SARS-CoV-2 IgG Antibodies
Nov 25, 2020 | Regulatory
2. CytoSorbents Highlights Largest Published Case Series To Date Using CytoSorb in Critically Ill COVID-19 Patients
Nov 25, 2020 | Clinical Trial
3. NeuroRx and Relief Announce Initial Successful Rsults from Expanded Access Use of RLF-100 (aviptadil) in Patients with Critical COVID-19 and Severe Comorbidity: 72% survival seen in ICU patients
Nov 24, 2020 | Clinical Trial
4. Vivacelle Bio Receives $5.3 Million Award from the US Navy for a Clinical Trial of VBI-S for Treatment of Hypovolemia of Septic Shock Due to COVID or other Pathogens
Nov 24, 2020 | Grant
5. ReiThera Announces its GRAd-COV2 COVID-19 Vaccine Candidate is Well Tolerated and Induces Clear Immune Responses in Healthy Subjects Aged 18-55 Years
Nov 24, 2020 | Clinical Trial
6. Longitude Prize Launches AMR Voices: Stories from the frontlines of antibiotic resistance during Covid-19
Nov 24, 2020 | Launch
7. Arizona BioTech Company Successfully Completes Pre-Clinical Testing for Vaccine Alternative to Prevent COVID-19 Infection, Ready for Human Trials
Nov 23, 2020 | Clinical Trial
8. FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19
Nov 21, 2020 | Regulatory
9. Regeneron’s REGEN-COV2 is First Antibody Cocktail for COVID-19 to Receive FDA Emergency Use Authorization
Nov 21, 2020 | Regulatory
10. Lilly’s Neutralizing Antibody bBmlanivimab (LY-CoV555) Receives Interim Authorization from Health Canada as a Treatment for COVID-19
Nov 20, 2020 | Regulatory
11. Persavita is Preparing for a Clinical Trial to Test its Experimental Natural Health Product in Covid-19
Nov 20, 2020 | Clinical Trial
12. FDA Grants Emergency Use Authorisation for Baricitinib in Hospitalised COVID-19 Patients Nine Months After Initial Hypothesis was Published by BenevolentAI
Nov 20, 2020 | Regulatory
13. Sosei Heptares’ COVID-19 Program Identifies Potent Broad Spectrum Anti-Viral Small Molecules for Further Development
Nov 20, 2020 | Clinical Trial
14. Baricitinib Receives Emergency Use Authorization from the FDA for the Treatment of Hospitalized Patients with COVID-19
Nov 19, 2020 | Regulatory
15. Icahn School of Medicine at Mount Sinai and Boehringer Ingelheim Collaborate on First Study to Evaluate Nintedanib in Patients with Fibrosing ILD following COVID-19 Infection
Nov 19, 2020 | Collaboration
16. RedHill Announces Unanimous DSMB Recommendation to Continue Phase 2/3 COVID-19 Study with Opaganib
Nov 19, 2020 | Regulatory
17. India’s Indigenous Solution to COVID-19 in Progress
Nov 19, 2020 | Pharma
18. In the lab, St. Jude Scientists Identify Possible COVID-19 Treatment
Nov 18, 2020 | Pharma
19. LANES, Fulgent Genetics and LA County Department of Health Services Collaborate to Fast-Track COVID-19 Test Results to Local Healthcare Providers
Nov 18, 2020 | Collaboration
20. BioLineRx Announces Initiation of Phase 1b Clinical Trial in Patients with Acute Respiratory Distress Syndrome (ARDS) Secondary to COVID-19 and Other Respiratory Viral Infections
Nov 18, 2020 | Clinical Trial
21. Diabetes, Hypertension May Increase Risk of COVID-19 Brain Complications
Nov 18, 2020 | Pharma
22. FDA Authorizes First COVID-19 Test for Self-Testing at Home
Nov 17, 2020 | Diagnostic
23. Ampio’s Phase I Study for Inhaled Ampion Advances to 3rd Group of COVID-19 Patients with Respiratory Distress
Nov 17, 2020 | Clinical Trial
24. RedHill Biopharma’s Second COVID-19 Candidate, RHB-107, Cleared by FDA for Phase 2/3 Study in Symptomatic COVID-19 Disease
Nov 17, 2020 | Clinical Trial
25. Samsung Biologics Announces Strategic Manufacturing Partnership with Lilly to Accelerate Delivery of COVID-19 Antibody Treatments
Nov 17, 2020 | Collaboration
26. TrippBio Reports Positive Results from Investigator-Initiated Clinical Trial of TD213 for the Treatment of Mild to Moderate COVID-19 Infections
Nov 16, 2020 | Clinical Trial
27. RedHill Biopharma Completes Enrollment for COVID-19 U.S. Phase 2 Study with Opaganib – Data Expected in the Coming Weeks
Nov 16, 2020 | Clinical Trial
28. INOVIO Announces Initiation of Phase 2 Segment of its Phase 2/3 Clinical Trial for its COVID-19 DNA Vaccine Candidate, INO-4800; Trial Will Be Funded by the U.S. Department of Defense
Nov 16, 2020 | Clinical Trial
29. Biological E. Limited Starts Phase I/II Clinical Trial of its COVID-19 Vaccine Candidate
Nov 16, 2020 | Clinical Trial
30. Johnson & Johnson and U.S. Department of Health & Human Services Expand Agreement to Support Next Phase of COVID-19 Vaccine Candidate Research and Development
Nov 14, 2020 | Collaboration
31. NeuroRx and Relief Therapeutics announce enrollment of 150 patients in phase 2b/3 trial of RLF-100 for Critical COVID-19 with Respiratory Failure
Nov 13, 2020 | Clinical Trial
32. Medicago and GSK announce start of Phase 2/3 clinical trials of adjuvanted COVID-19 vaccine candidate
Nov 12, 2020 | Clinical Trial
33. AstraZeneca Partners with CCT to Conduct COVID-19 Vaccine Clinical Trials in Arizona
Nov 12, 2020 | Collaboration
34. Leading Generic Drug Makers Unite to Pledge Capacity for Developing and Delivering Affordable COVID-19 Interventions as Pandemic Intensifies
Nov 11, 2020 | Collaboration
35. NYU Langone Health to Enroll Healthy Volunteers In Clinical Trial for COVID-19 Vaccine
Nov 11, 2020 | Clinical Trial
36. ADVAITE’s High Complexity CLIA Lab Receives Authorization from Yale University to Offer Highly Accurate COVID-19 SalivaDirect™ Test
Nov 11, 2020 | Regulatory
37. Sagent Pharmaceuticals Launches Phase 2 Trial to Evaluate Camostat Mesilate for COVID-19 Treatment
Nov 11, 2020 | Clinical Trial
38. Mountain Valley MD Files Patent to Protect Science Achievement in Solubilization of ivermectin Without Organic Solvents and Its Application to COVID-19 and Other Therapies
Nov 11, 2020 | Regulatory
39. The first interim data analysis of the Sputnik V vaccine against COVID-19 phase III clinical trials in the Russian Federation demonstrated 92% efficacy
Nov 11, 2020 | Clinical Trial
40. Co-Diagnostics Shown to be Effective in COVID-19 Saliva PCR Tests Without Sample Extraction
Nov 11, 2020 | Clinical Trial
41. Ampio’s Phase I Study For Inhaled Ampion Advances To 2nd Group Of COVID-19 Patients With Respiratory Distress
Nov 10, 2020 | Clinical Trial
42. CollPlant Announces Early Development Program of Antiviral Agent for Potential Treatment of COVID-19 Patients
Nov 10, 2020 | Clinical Trial
43. New Research Published in The Lancet Psychiatry Finds COVID-19 Associated with Increased Risk for Developing Psychiatric Disorders
Nov 9, 2020 | Clinical Trial
44. New COVID Vaccine Clinical Trials Enrolling At Local Lake Charles Research Site
Nov 9, 2020 | Clinical Trial
45. CARE GA Receives Study May Proceed Letter from US FDA to Initiate Phase II Clinical Trial of Senhwa’s Silmitasertib in COVID-19 Patients
Nov 6, 2020 | Clinical Trial
46. NeuroRx and Relief Therapeutics Announce Continuation of RLF-100 trial for Treatment of COVID-19 Respiratory Failure: Trial is on Track to Complete Enrollment in 2020
Nov 5, 2020 | Clinical Trial
47. New Research Study Validates Performance and Accuracy of Truvian Sciences’ Easy Check COVID-19 IgM/IgG Test
Nov 3, 2020 | Regulatory
48. Senhwa Announces Multiple IND application submissions to US FDA for Silmitasertib as a Potential Treatment for COVID-19
Nov 2, 2020 | Regulatory
49. Emmes Employees Co-Author COVID-19 Vaccine Report for the New England Journal of Medicine
Nov 2, 2020 | Clinical Trial
50. RevImmune Advances New Immunotherapy in COVID-19
Nov 2, 2020 | Clinical Trial
51. Immunic, Inc. Announces 200 Patients Enrolled in Its Phase 2 CALVID-1 Trial of IMU-838 for the Treatment of Moderate COVID-19, Allowing for Main Phase 2 Efficacy Analysis to Proceed
Nov 2, 2020 | Clinical Trial
Related Post: Insights+: COVID-19 Healthcare News Monthly Updates – October 2020
The post Insights+: COVID-19 Healthcare News Monthly Updates – November 2020 first appeared on PharmaShots.
